Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASS-14: Single-hormone closed-loop vs SAPT in T1D
NCT02846831Phase 2Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in type 1 diabetes mellitus (T1D), sponsored by Montreal Clinical Research Institute. Primary endpoint: Time in Range at 288 hours. Started Jan 2019; status: completed.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02846831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02846831.